Clinical isolates of Providencia and Proteus with relative aminoglycoside resistance were tested for susceptibility to combinations of gentamicin or tobramycin with cephalothin or cefazolin. The minimal bactericidal concentration of aminoglycoside for one-third of the strains was reduced by fourfold or more in the presence of one-fourth of the minimal bactericidal concentration of either cephalosporin. This effect was achieved by clinically attainable concentrations of cephalothin or cefazolin.
Clinical isolates of Providencia and Proteus with relative aminoglycoside resistance were tested for susceptibility to combinations of gentamicin or tobramycin with cephalothin or cefazolin. The minimal bactericidal concentration of aminoglycoside for one-third of the strains was reduced by fourfold or more in the presence of one-fourth of the minimal bactericidal concentration of either cephalosporin. This effect was achieved by clinically attainable concentrations of cephalothin or cefazolin.
Although Providencia has been an uncommon cause of clinical infections, recent epidemics have been described in hospitalized patients, particularly in burn units (5, 14, 15) . We have noted a gradually increasing incidence of clinical isolates of Providencia in our hospital, although serious infections have remained rare. In vitro studies on these strains have indicated relative resistance to all aminoglycoside antibiotics. Most strains have required minimal inhibitory and bactericidal concentrations of 12.5 to 50 gg of gentamicin per ml. A synergistic effect of penicillins or cephalosporins with aminoglycosides has previously been demonstrated against Enterobacteriaceae (3, 4, 10) and Pseudomonas (6, 12, 17) . We have therefore studied nine strains of Providencia and seven strains of the related genus, Proteus, which were moderately or highly resistant to gentamicin. Our purpose was to evaluate two cephalosporins, cephalothin and cefazolin, in crossover combination with two aminoglycosides, gentamicin and tobramycin, for possible in vitro synergy against these organisms.
MATERIALS AND METHODS Providencia and Proteus strains were collected from the clinical microbiology laboratory on the basis of gentamicin resistance by routine disk sensitivity testing. Tube dilution assays were done in MuellerHinton broth as previously described (9) . Grid studies were performed so that double dilutions of cephalothin, and cefazolin were combined with double dilutions of gentamicin or tobramycin. This tamicin. This usually required less than 62 ,ug of cephalosporin per ml, a clinically attainable level of either cephalothin or cefazolin. Figure 2 shows the effect of each combination of antibiotics on the MBC of Providencia strains. A synergistic effect occurred in 89% of the tests, but in several instances 125 to 250,g of a cephalosporin per ml was required.
The results of studies carried out with Proteus species are presented in Fig. 3 (Fig. 3) . Figure 4 shows that only 65% of Proteus strains were susceptible to a synergistic effect on the MBC of aminoglycosides and approximately half of these required greater than 62 usg of a cephalosporin per ml to achieve this result. added to > >dd5 ftC NBC of CZ 500 >500 >500 500 >500 >500 >500 >500 500 NBC of CF 500 500 500 500 500 >500 >500 >500 >500 lAg/all Cq/0If N(BCo/f CZl 500 >500 >500 >500 >500 >500 >250 >500 >500 18C /of >500 500 >500 *500 >500 >250 >500 500 VOL. 5, 1974 (11) . Our findings confirm their results and further define the bacteriostatic and bactericidal activity of this combination. In addition, the present data suggest that cefazolin may be more effective than cephalothin in producing synergy with aminoglycosides.
Recent reports have suggested that the combination of cephalothin and gentamicin is potentially more nephrotoxic than either drug alone (1, 7, 8, 13) . Since cefazolin has shown somewhat greater nephrotoxic potential than cephalothin in experimental studies (16) , renal function should be carefully monitored during the administration of any cephalosporin-aminoglycoside combination.
